In The News
Hytera can’t dodge finding it committed ‘industrial theft’ of Motorola’s source code
Judge approves $31.5M settlement in junior doctors class action
ASIC claims crypto firm Binance denied protections to derivatives investors
Barrister who accepted briefs for appearances on same day referred to watchdog
Melbourne law firm argues 700 clients can’t sue for negligence in class action
Hall & Wilcox brings on Moray & Agnew public law specialist
Slashing funder’s stolen wages cut could deter public interest cases, court told
Law firm files first class action over Google’s ad tech dominance
Landmark $50M settlement over Meta’s Cambridge Analytica scandal
Qantas to pay $120M to settle ground crew outsourcing case
Please login to bookmarkClose

Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au